CHINA RESOURCES PHARMACEUTICAL GROUP LTDCHINA RESOURCES PHARMACEUTICAL GROUP LTDCHINA RESOURCES PHARMACEUTICAL GROUP LTD

CHINA RESOURCES PHARMACEUTICAL GROUP LTD

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.01 B‬EUR
‪494.02 M‬EUR
‪31.37 B‬EUR
‪1.82 B‬
Beta (1Y)
1.04
Employees (FY)
‪72.99 K‬
Change (1Y)
‪+5.99 K‬ +8.93%
Revenue / Employee (1Y)
‪474.32 K‬EUR
Net income / Employee (1Y)
‪7.47 K‬EUR

About CHINA RESOURCES PHARMACEUTICAL GR


Headquarters
Hong Kong
Founded
1938
ISIN
HK0000311099
FIGI
China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. It operates through the following segments: Manufacturing, Distribution, Retail, and Others. The Manufacturing segment handles the research and development, manufacture, and sale of pharmaceutical and healthcare products. The Distribution segment focuses on the distribution, warehousing, logistics, and pharmaceutical supply chain solutions and services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. The Retail segment deals with the operation of retailing of pharmacy stores. The Others segment comprises of property holding. The company was founded in 1938 and is headquartered in Hong Kong.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 640 is 0.63 EUR — it has decreased by −3.10% in the past 24 hours. Watch CHINA RESOURCES PHARMACEUTICAL GROUP LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CHINA RESOURCES PHARMACEUTICAL GROUP LTD stocks are traded under the ticker 640.
640 stock has fallen by −3.85% compared to the previous week, the month change is a −8.09% fall, over the last year CHINA RESOURCES PHARMACEUTICAL GROUP LTD has showed a 5.04% increase.
We've gathered analysts' opinions on CHINA RESOURCES PHARMACEUTICAL GROUP LTD future price: according to them, 640 price has a max estimate of 1.18 EUR and a min estimate of 0.70 EUR. Watch 640 chart and read a more detailed CHINA RESOURCES PHARMACEUTICAL GROUP LTD stock forecast: see what analysts think of CHINA RESOURCES PHARMACEUTICAL GROUP LTD and suggest that you do with its stocks.
640 reached its all-time high on May 10, 2023 with the price of 0.90 EUR, and its all-time low was 0.38 EUR and was reached on Mar 15, 2022. View more price dynamics on 640 chart.
See other stocks reaching their highest and lowest prices.
640 stock is 0.00% volatile and has beta coefficient of 1.04. Track CHINA RESOURCES PHARMACEUTICAL GROUP LTD stock price on the chart and check out the list of the most volatile stocks — is CHINA RESOURCES PHARMACEUTICAL GROUP LTD there?
Today CHINA RESOURCES PHARMACEUTICAL GROUP LTD has the market capitalization of ‪4.01 B‬, it has decreased by −0.10% over the last week.
Yes, you can track CHINA RESOURCES PHARMACEUTICAL GROUP LTD financials in yearly and quarterly reports right on TradingView.
CHINA RESOURCES PHARMACEUTICAL GROUP LTD is going to release the next earnings report on Mar 25, 2025. Keep track of upcoming events with our Earnings Calendar.
640 earnings for the last half-year are 0.05 EUR per share, whereas the estimation was 0.06 EUR, resulting in a −4.33% surprise. The estimated earnings for the next half-year are 0.03 EUR per share. See more details about CHINA RESOURCES PHARMACEUTICAL GROUP LTD earnings.
CHINA RESOURCES PHARMACEUTICAL GROUP LTD revenue for the last half-year amounts to ‪16.52 B‬ EUR, despite the estimated figure of ‪16.57 B‬ EUR. In the next half-year revenue is expected to reach ‪16.83 B‬ EUR.
640 net income for the last half-year is ‪337.39 M‬ EUR, while the previous report showed ‪355.32 M‬ EUR of net income which accounts for −5.05% change. Track more CHINA RESOURCES PHARMACEUTICAL GROUP LTD financial stats to get the full picture.
CHINA RESOURCES PHARMACEUTICAL GROUP LTD dividend yield was 3.31% in 2023, and payout ratio reached 25.03%. The year before the numbers were 2.53% and 24.24% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 25, 2024, the company has ‪72.99 K‬ employees. See our rating of the largest employees — is CHINA RESOURCES PHARMACEUTICAL GROUP LTD on this list?
Like other stocks, 640 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHINA RESOURCES PHARMACEUTICAL GROUP LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHINA RESOURCES PHARMACEUTICAL GROUP LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHINA RESOURCES PHARMACEUTICAL GROUP LTD stock shows the sell signal. See more of CHINA RESOURCES PHARMACEUTICAL GROUP LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.